From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, CA (MEH); Division of Research, Kaiser Permanente Northern California, Oakland (AHK-S, SAS); Indiana University School of Medicine, Regenstrief Institute, Inc., Indianapolis, IN (KK).
J Am Board Fam Med. 2018 Sep-Oct;31(5):724-732. doi: 10.3122/jabfm.2018.05.180092.
Hazardous alcohol use with depression may exacerbate health conditions and complicate medical care. We examined the rate of depression screening by alcohol use severity among primary care patients screened for hazardous alcohol use and, among those screened, examined patterns of significant depressive symptoms.
Using cross-sectional data from primary care patients (n = 2,894,906), we examined past-90-day alcohol use (number of typical drinking days/week and typical number of drinks consumed daily); depression screening rates (using the Patient Health Questionnaire 9 [PHQ-9]); and symptom severity, demographics, and prevalence of selected psychiatric diagnoses.
Within 30 days of routine, in-clinic alcohol use screening by medical assistants, 2.4% (n = 68,686) of patients also completed a PHQ-9; these patients were more likely to be female, younger, white, Medicaid insured, and to have a nondepressive psychiatric diagnosis and a lower Charlson comorbidity score. Abstainers and moderate drinkers (1 to 7 drinks/week or 1 to 4 drinks/week for women and individuals >65 years or for men ≤65 years, respectively) were less likely than hazardous drinkers (exceeding weekly limits) to complete the PHQ-9 or to have significant depressive symptoms (PHQ-9 score ≥10). Nonwhite patients with higher Charlson comorbidity scores were more likely to endorse significant depressive symptoms.
Only a small fraction of patients in this cohort were screened for depression. Nonwhite patients and those with higher comorbidity burden were more likely to report depression but less likely to be screened. These discrepancies between depression-screening rates and significant depressive symptoms suggest that screening for depression should be enhanced in these at-risk groups.
有抑郁问题的危险饮酒行为可能会加重健康状况,并使医疗护理复杂化。我们研究了在接受危险饮酒筛查的初级保健患者中,根据酒精使用严重程度进行抑郁筛查的比率,以及在接受筛查的患者中,检查有显著抑郁症状的模式。
我们使用来自初级保健患者的横断面数据(n=2894906),检查了过去 90 天的饮酒情况(每周典型饮酒天数/周和每天典型饮酒量);抑郁筛查率(使用患者健康问卷 9[PHQ-9]);以及症状严重程度、人口统计学特征和选定精神科诊断的患病率。
在医疗助理常规进行门诊酒精使用筛查后的 30 天内,2.4%(n=68686)的患者还完成了 PHQ-9;这些患者更可能是女性、年轻、白人、医疗补助保险,并有非抑郁性精神科诊断和较低的 Charlson 合并症评分。禁欲者和适度饮酒者(每周 1 至 7 次或每周 1 至 4 次,分别为女性和年龄大于 65 岁或男性年龄小于 65 岁)比危险饮酒者(超过每周限制)更不可能完成 PHQ-9或有显著抑郁症状(PHQ-9 评分≥10)。Charlson 合并症评分较高的非白人患者更有可能出现显著抑郁症状。
在这个队列中,只有一小部分患者接受了抑郁筛查。非白人患者和合并症负担较高的患者更有可能报告抑郁,但接受筛查的可能性较低。这些抑郁筛查率和显著抑郁症状之间的差异表明,应该在这些高危人群中加强抑郁筛查。